Keywords: biogen, idec, closes, 2nd-qtr, above, expectations, world
Biogen Idec closes 2nd-qtr above expectations
Article | 09 August 2004
The world's third-largest biotechnology firm, Biogen Idec, has beatenexpectations for the second quarter of 2004 by posting a profit of $827,000, or ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
